Which Are the Emerging Companies in the Respiratory Devices Industry in 2025?

Introduction

The global focus on respiratory health has never been sharper. Moving beyond the traditional paradigms of ventilators and inhalers, a new generation of companies is leveraging advanced technology to create a more proactive, less invasive, and data-driven future for respiratory medicine. From AI-powered acoustic monitoring to revolutionary critical care devices, these upcoming players from respiratory devices industry are poised to make a significant impact on patient outcomes and healthcare efficiency.

Emerging Players of Respiratory Devices Industry

X-COR Therapeutics

X-COR Therapeutics: This Boston-based company is developing an ultralow-blood-flow extracorporeal CO2? removal (ECCO2?R) device. The goal is to offer a bridge for patients with hypercapnic failure or Acute Respiratory Distress Syndrome (ARDS), reducing their dependence on full mechanical ventilation and the high risks associated with ECMO

Hospitech Respiration

Hospitech Respiration: Targeting a major risk in the ICU, Hospitech's AnapnoGuard system automates the critical maintenance of endotracheal tubes. By continuously monitoring cuff pressure and clearing secretions, it aims to significantly reduce the incidence of Ventilator-Associated Pneumonia (VAP), a common and dangerous complication

CorVent Medical

CorVent Medical: Addressing the need for surge capacity and flexibility, CorVent's "RESPOND" ventilator platform is designed for both invasive and non-invasive use. Its portability and adaptability make it a crucial tool for resource-constrained environments and emergency preparedness.

Circadia Health

Circadia Health: With its C100 and C200 devices, Circadia enables continuous, contact-free respiratory monitoring. By tracking breathing rates and patterns, the system can provide clinicians with early warnings of patient deterioration, allowing for timely intervention.

Respira Labs

Respira Labs: Using a novel approach based on acoustic resonance, Respira Labs is developing a wearable, non-invasive monitor to assess lung function. By analyzing sound waves, their device can estimate lung capacity and detect trapped air, offering a powerful new tool for managing conditions like COPD and asthma.

Strados Labs

Strados Labs: The RESP Biosensor from Strados Labs is a wearable that continuously captures and analyzes lung sounds. By identifying coughs, wheezing, and other acoustic biomarkers, it provides objective data to help manage chronic respiratory diseases and predict exacerbations.

NanoVation

NanoVation: This Israeli company is focused on bringing respiratory monitoring into the home. Its technology is designed to detect subtle changes in breathing patterns in patients with chronic conditions, enabling early intervention before a hospital visit becomes necessary.

Alveofit

Alveofit: Based in India, Alveofit has developed a comprehensive connected care platform. Combining a portable spirometer with sensors and AI-driven tools, it allows for effective remote monitoring and management of respiratory patients outside of the hospital setting.

Aerin Medical

Aerin Medical: Focusing on the root causes of nasal congestion, Aerin Medical offers non-invasive, in-office treatments for nasal airway obstruction (VivAer) and chronic rhinitis (RhinAer). Using radiofrequency energy, these therapies provide a durable alternative to daily medications or invasive surgery.

Resmonics AG

Resmonics AG: This Swiss company applies acoustic AI in a broader healthcare context. Its technology can analyze ambient and patient sounds in real-time to detect changes in breathing, identify potential hygiene issues, and help prevent the spread of respiratory infections within clinical environments.

Conclusion

The respiratory devices market is being transformed by a combination of pioneering medtech innovators and established medical device leaders. Emerging companies leveraging AI, advanced sensors, and novel delivery systems are driving innovation, while global players continue to lead with robust portfolios and large-scale distribution. Together, these stakeholders are accelerating the shift toward more personalized, proactive, and patient-centered respiratory care, ensuring better outcomes and improved quality of life for millions worldwide.

Anushka Gore  

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behavio…